BioCryst Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2013-03-31 | $17k | 14k | 1.19 |
| 2012-12-31 | $23k | 16k | 1.44 |
| 2012-09-30 | $83k | 20k | 4.24 |
| 2012-06-30 | $189k | 48k | 3.97 |
| 2011-12-31 | $75k | 30k | 2.47 |
| 2011-09-30 | $42k | 15k | 2.76 |
| 2011-06-30 | $238k | 62k | 3.82 |
| 2011-03-31 | $136k | 36k | 3.79 |
| 2010-12-31 | $331k | 64k | 5.17 |